体检人群脂肪肝患病率及危险因素

doi:10.3969/j.issn.1674-490X.2021.01.007

摘要/Abstract

摘要： 目的调查分析西安市某体检人群脂肪肝患病率及相关危险因素,为今后采取针对性地预防和治疗提供依据。方法选取2017年6月至2019年6月在西安市第三医院具有完整体检资料的健康体检者9 096例,确定脂肪肝患病者,同时收集人体测量学、生化免疫指标、疾病史,通过年龄、性别分层研究其患病情况。资料分析采用卡方检验、t检验和多因素Logistic回归。结果 9 096例调查对象中,共检出脂肪肝2 290例,患病率25.18%。男性患病率显著高于女性(P<0.01);女性60~69岁患病率最高(22.67%),男性30~39岁患病率最高(41.29%)。脂肪肝组体质量指数、总胆固醇、三酰甘油、低密度脂蛋白、空腹血糖、血尿酸、收缩压、舒张压的均值水平显著高于非脂肪肝组,高密度脂蛋白显著低于非脂肪肝组(P<0.01);多元回归分析显示,年龄、体质量指数、舒张压、空腹血糖、三酰甘油、总胆固醇、高密度脂蛋白、血尿酸、胆囊疾病是脂肪肝的危险因素。结论西安市体检人群脂肪肝患病率男性高于女性,超质量及肥胖、血脂异常、高血压、高血糖、高尿酸血症及胆囊疾病是其主要危险因素。

关键词: 脂肪肝, 患病率, 危险因素, 代谢紊乱

Abstract: Objective To analyze the prevalence and related risk factors of fatty liver disease in a population undergoing physical examination in Xi'an city and provide basis for targeted prevention and treatment of fatty liver in the future. Methods 9 096 healthy adults who had physical examination with complete clinical records in Xi'an No.3 hospital were enrolled, identified with FLD. At the same time, anthropometry, biochemical immune indicators and disease history were collected, and the disease status was studied with age and gender stratification. Data analysis was performed using the χ² test, t-test, and logistic regression analysis. Results Among the 9 096 cases, a total of 2 290 cases of FLD were detected with ultrasound examination, with a prevalence rate of 25.18%. The prevalence was significantly higher in males than that in females(P<0.01). The prevalence was highest in females aged 60-69 years(22.67%)and highest in males aged 30-39 years(41.29%). The mean levels of body mass index, total cholesterol, triglyceride, low-density lipoprotein, fasting blood glucose, blood uric acid, systolic blood pressure and diastolic blood pressure in the fatty liver group were significantly higher than those in the non-fatty liver group, while the high-density lipoprotein was significantly lower than those in the non-fatty liver group(P<0.01). Multivariate logistic regression analysis showed that age, body mass index, diastolic blood pressure, fasting blood glucose, triglyceride, total cholesterol, blood uric acid, gallbladder disease were risk factors for fatty liver. Conclusion The prevalence of FLD is higher in males than in females among the physical examination population in xi'an city. Overweight and obesity, dyslipidemia, hypertension, hyperglycemia, hyperuricemia and gallbladder disease were the main risk factors.

Key words: fatty liver, prevalence, risk factors, metabolic disorders

中图分类号:

R195.4

郝婕,张倩,王媛,徐俊荣. 体检人群脂肪肝患病率及危险因素[J]. 医学研究与教育, 2021, 38(1): 45-52.

参考文献

[1] 施军平, 范建高. 中国脂肪性肝病诊疗规范化的专家建议(2019年修订版)[J]. 中华肝脏病杂志, 2019, 27(10): 748-753. DOI: 10.3969/j.issn.1001-5256.2019.11.007.
[2] FAN J G, FARRELL G C. Epidemiology of non-alcoholic fatty liver disease in China[J]. J Hepatol, 2009, 50(1): 204-210. DOI: 10.1016/j.jhep.2008.10.010.
[3] YOUNOSSI Z M, KOENIG A B, ABDELATIF D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes[J]. Hepatology, 2016, 64(1): 73-84. DOI: 10.1002/hep.28431.
[4] 中华医学会肝病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊疗指南(2010年修订版)[J]. 中华肝脏病杂志, 2010, 18(3): 163-166. DOI: 10.3760/cma.j.issn.1007-3418.2010.03.002.
[5] 中国肥胖问题工作组. 中国成人超重和肥胖症预防与控制指南(节录)[J]. 营养学报, 2004, 26(1): 1-1.
[6] 中国成人血脂异常防治指南修订联合委员会. 中国成人血脂异常防治指南(2016年修订版)[J]. 中华心血管病杂志, 2016, 44(10): 833-853. DOI: 10.3760/cma.j.issn.0253-3758.2016.10.005.
[7] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2013年版)[J]. 中华糖尿病杂志, 2014(7): 447-498. DOI: 10.3760/cma.j.issn.1674-5809.2014.07.004.
[8] 中国高血压防治指南修订委员会. 中国高血压防治指南2010[J]. 中华心血管病杂志, 2011, 39(7): 579-616. DOI: 10.3760/cma.j.issn.0253-3758.2011.07.002.
[9] 中国医师协会肾脏内科医师分会. 中国肾脏疾病高尿酸血症诊治的实践指南(2017版)[J]. 中华医学杂志, 2017, 97(25): 1927-1936. DOI: 10.3760/cma.j.issn.0376-2491.2017.25.003.
[10] 王中丽, 夏冰, 陈向群, 等. 武汉地区脂肪肝的流行现状及危险因素分析[J]. 武汉大学学报(医学版), 2006, 27(3): 319-322. DOI: 10.3969/j.issn.1671-8852.2006.03.012.
[11] HU X N, HUANG Y Q, BAO Z J, et al. Prevalence and factors associated with nonalcoholic fatty liver disease in Shanghai work-units[J]. BMC Gastroenterol, 2012, 12: 123. DOI: 10.1186/1471-230x-12-123.
[12] 向国卿, 孟晓丹, 王炳元. 沈阳市不同职业人群脂肪肝的流行现状分析[J]. 临床肝胆病杂志, 2010, 26(3): 283-285. DOI: 10.3969/j.issn.1001-5256.2010.03.021.
[13] YAN J, XIE W, OU W N, et al. Epidemiological survey and risk factor analysis of fatty liver disease of adult residents, Beijing, China[J]. J Gastroenterol Hepatol, 2013, 28(10): 1654-1659. DOI: 10.1111/jgh.12290.
[14] 张建华. 青岛市企事业单位体检人群脂肪性肝病的患病率及相关因素分析[D]. 青岛大学, 2009: 4-5. DOI: 10.7666/d.y1469064.
[15] 韩涛, 张艳男, 荣胜忠, 等. 哈尔滨市区居民脂肪肝患病率与危险因素分析[J]. 哈尔滨医科大学学报, 2013, 47(4): 363-366. DOI: 10.3969/j.issn.1000-1905.2013.04.020.
[16] 秦恳, 马秀英, 吴琴琴, 等. 成都地区人群脂肪肝与代谢综合征及高尿酸血症的关系探讨[J]. 四川医学, 2014, 35(3): 321-323.
[17] 余纪会, 唐兰, 赵文苹, 等. 重庆地区体检人群脂肪肝与其他常见代谢性疾病患病情况及相关性分析[J]. 公共卫生与预防医学, 2019, 30(3): 87-90. DOI: 10.3969/j.issn.1006-2483.2019.03.020.
[18] 赵健, 郭忠琴, 陆波, 等. 银川市某体检人群脂肪肝与高尿酸血症、体重指数的相关性研究[J]. 现代预防医学, 2014, 41(24): 4451-4453.
[19] 闫蓉, 牛春燕, 天宇, 等. 乌鲁木齐地区汉族成人脂肪肝及其相关危险因素的多元回归分析[J]. 胃肠病学和肝病学杂志, 2010, 19(12): 1120-1123. DOI: 10.3969/j.issn.1006-5709.2010.12.018.
[20] LONARDO A, NASCIMBENI F, BALLESTRI S, et al. Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps[J]. Hepatology, 2019, 70(4): 1457-1469. DOI: 10.1002/hep.30626.
[21] ANDERSON E L, HOWE L D, JONES H E, et al. The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis[J]. PLoS One, 2015, 10(10): e0140908. DOI: 10.1371/journal.pone.0140908.
[22] EGUCHI Y, HYOGO H, ONO M, et al. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study[J]. J Gastroenterol, 2012, 47(5): 586-595. DOI: 10.1007/s00535-012-0533-z.
[23] VOLZKE H, SCHWARZ S, BAUMEISTER S E, et al. Menopausal status and hepatic steatosis in a general female population[J]. Gut, 2007, 56(4): 594-595. DOI: 10.1136/gut.2006.115345.
[24] 王缕, 张志红, 冯健, 等. 泸州市某单位体检人群脂肪肝患病率及危险因素分析[J]. 现代预防医学, 2018, 45(6): 1109-1113.
[25] TOMINAGA K, FUJIMOTO E, SUZUKI K, et al. Prevalence of non-alcoholic fatty liver disease in children and relationship to metabolic syndrome, insulin resistance, and waist circumference[J]. Environ Health Prev Med, 2009, 14(2): 142-149. DOI: 10.1007/s12199-008-0074-5.
[26] DAMSGAARD C T, MICHAELSEN K F, MOLBO D, et al. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants[J]. Lancet, 2016, 387(10026): 1377-1396. DOI: 10.1016/s0140-6736(16)30054-x.
[27] 王维华, 冯刘欣, 邱琳, 等. 2007—2015年陕西省成年居民BMI的变化情况[J]. 中华疾病控制杂志, 2019(7): 763-768. DOI: 10.16462/j.cnki.zhjbkz.2019.07.005.
[28] FUNG J, LEE C K, CHAN M, et al. High prevalence of non-alcoholic fatty liver disease in the Chinese-results from the Hong Kong liver health census[J]. Liver Int, 2015, 35(2): 542-549. DOI: 10.1111/liv.12619.
[29] 张华捷, 庄辉, 刘学恩. 脂肪肝的流行病学研究进展[J]. 中华流行病学杂志, 2004, 25(7): 630-632. DOI: 10.3760/j.issn:0254-6450.2004.07.022.
[30] YOUNOSSI Z, GOLABI P, DEAVILA L, et al. THU-437-The Global Epidemiology on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in patients with type 2 diabetes mellitus: a systematic review and meta-analysis[J]. J Hepatol, 2019, 70(1): e349-e350. DOI: 10.1016/s0618-8278(19)30684-x.
[31] 戴漪思, 殷小平, 段朋朋. 非酒精性脂肪肝影像诊断研究进展[J]. 医学研究与教育, 2019, 36(3): 39-44. DOI: 10.3969/j.issn.1674-490X.2019.03.007.
[32] 延华, 鲁晓岚, 高艳琼, 等. 西北地区脂肪性肝病的流行病学调查研究[J]. 中华肝脏病杂志, 2015, 23(8): 622-627. DOI: 10.3760/cma.j.issn.1007-3418.2015.08.013.
[33] ESLAM M, SANYAL A J, GEORGE J, et al. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease[J]. Gastroenterology, 2020, 158(7): 1999-2014.e1. DOI: 10.1053/j.gastro.2019.11.312.
[34] DIEHL A M. Fatty liver, hypertension, and the metabolic syndrome[J]. Gut, 2004, 53(7): 923-924. DOI: 10.1136/gut.2003.037309.
[35] JENSEN T, NIWA K, HISATOME I, et al. Increased serum uric acid over five years is a risk factor for developing fatty liver[J]. Sci Rep, 2018, 8: 11735. DOI: 10.1038/s41598-018-30267-2.
[36] 徐承富, 厉有名. 非酒精性脂肪性肝病与高尿酸血症[J]. 实用肝脏病杂志, 2017, 20(3): 260-262. DOI: 10.3969/j.issn.1672-5069.2017.03.002.
[37] AHMED F, BALOCH Q, MEMON Z A, et al. An observational study on the association of nonalcoholic fatty liver disease and metabolic syndrome with gall stone disease requiring cholecystectomy[J]. Ann Med Surg, 2017, 17: 7-13. DOI: 10.1016/j.amsu.2017.03.015.
[38] LI X, GAO P J. Fatty liver increases gallstone disease risk in younger Chinese patients[J]. Medicine, 2019, 98(22): e15940. DOI: 10.1097/md.0000000000015940.
[39] ZHENG Y M, BAI X S, YAO G B, et al. Risk factors of gallbladder polyps formation in East Asian population: A meta-analysis and systematic review[J]. Asian J Surg, 2020, 43: 52-59. DOI: 10.1016/j.asjsur.2019.03.015.